Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...

For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...

Early physical therapy initiation at cancer diagnosis can prevent or minimize treatment-related side effects, enhancing ...

like during the COVID-19 pandemic. “Unfortunately, many of these same inequities can also be found in the fight against prostate cancer,” said Speaker Ron Mariano. Racial inequities in ...

URBANA, Ill. (WICS) — March is Deep Vein Thrombosis Awareness Month, highlighting a serious but often overlooked condition. As March comes to a close, I spoke with a doctor from Carle Hospital about ...